We are live on ! Find out more
CELG.RT icon

Bristol-Myers Squibb Rights
CELG.RT

15 hedge funds and large institutions have $26.5K invested in Bristol-Myers Squibb Rights in 2026 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% less funds holding

Funds holding: 17 → 15 (-2)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

99% less capital inflows, than outflows

Capital inflows: $24 | Capital outflows: $3.74K

Holders
15
Holders Change
-2
Holders Change %
-11.76%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$20
2
NWM
Navigoe Wealth Management
California
+$4

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Securities
Two Sigma Securities
New York
-$1.88K
2
Private Advisor Group
Private Advisor Group
New Jersey
-$1.74K
3
UBS Group
UBS Group
Switzerland
-$106
4
Bank of America
Bank of America
North Carolina
-$2
5
First Pacific Financial
First Pacific Financial
Washington
-$1

CELG.RT Hedge Fund Activity: Q2 2026 in Review

15 of the 8,358 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Rights (CELG.RT) for Q2 2026, worth a combined $26.5K — down 30% from $37.9K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CELG.RT and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was Wells Fargo, adding an estimated $20. The largest seller was Two Sigma Securities, exiting entirely with an estimated $1.88K sold.

  • 15 institutional investors held Bristol-Myers Squibb Rights (CELG.RT) as of Q2 2026, down from 17 in Q1 2026.
  • Funds reported $26.5K of Bristol-Myers Squibb Rights stock for Q2 2026, down 30% quarter-over-quarter.
  • 1 fund opened new Bristol-Myers Squibb Rights positions in Q2 2026 and 3 closed out, a net change of -2 holders.
  • The largest Bristol-Myers Squibb Rights buyer in Q2 2026 was Wells Fargo, an estimated $20 added.
  • The largest Bristol-Myers Squibb Rights seller in Q2 2026 was Two Sigma Securities, an estimated $1.88K sold.

Based on aggregated 13F filings for Q2 2026.